We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Diabetes & Endocrinology

Integrating Polygenic Risk Scores and Lifestyle Factors to Predict Type 2 Diabetes Onset in the Japanese Population

MedXY Editorial Team•Oct 12, 2026•Diabetes & Endocrinology
Japanese Populationlifestyle factorsPolygenic Risk ScoresRisk Predictiontype 2 diabetes

Highlight

  • Polygenic risk scores (PRS) significantly predict type 2 diabetes development in Japanese populations independent of traditional risk factors.
  • Healthy lifestyle factors such as regular exercise, and absence of hypertension or dyslipidemia are associated with reduced diabetes risk, even in individuals with high genetic susceptibility.
  • Adding PRS to conventional risk prediction models improves diagnostic discrimination for identifying individuals at higher risk of developing diabetes.

Study Background

Type 2 diabetes mellitus (T2DM) represents a major public health burden globally, including in East Asia, where prevalence continues to increase due to aging populations and lifestyle changes. Japanese populations exhibit unique genetic and environmental factors influencing diabetes risk. While conventional risk predictors—such as age, body mass index (BMI), hypertension, and dyslipidemia—are well established, the contribution of polygenic risk scores (PRS), which aggregate genetic susceptibility across multiple variants, remains underexplored in this ethnic group. Integrating PRS with lifestyle factors could provide a more precise risk stratification to guide personalized prevention.

Study Design

This investigation combined two cohorts to examine associations between PRS, lifestyle, and T2DM onset in Japanese adults. The Shika resident cohort (n=895) enabled a cross-sectional evaluation, whereas the Toshiba worker cohort (n=7019) permitted longitudinal risk assessment. PRS were derived from genome-wide association studies (GWAS) targeting East Asian populations and stratified participants into low, intermediate, and high genetic risk groups. Diabetes diagnosis was established by hemoglobin A1c (HbA1c) levels, fasting blood glucose, self-reported diagnosis, or use of antidiabetic medication. Multivariate logistic regression and Cox proportional hazards models assessed the independent and combined effects of PRS and lifestyle factors—including exercise habits, hypertension, and dyslipidemia status—on diabetes risk.

Key Findings

The study revealed a robust association between higher PRS and increased risk of T2DM in both cohorts. In the cross-sectional resident cohort, individuals with high PRS had an odds ratio (OR) of 4.51 (95% confidence interval [CI], 2.53–8.04) for diabetes compared to those with low PRS. Similarly, in the longitudinal worker cohort, high PRS predicted diabetes onset with a hazard ratio (HR) of 1.50 (95% CI, 1.23–1.83). These associations persisted after adjusting for confounders such as age, BMI, and presence of comorbidities.

Importantly, lifestyle factors modified diabetes risk particularly among genetically susceptible individuals. Regular exercise, along with the absence of hypertension or dyslipidemia, correlated with a significant reduction in incident diabetes risk within the high PRS group. This finding underscores the potential of lifestyle modification to mitigate genetic predisposition effects.

Integration of PRS into traditional prediction models enhanced discrimination accuracy for diabetes risk, supporting its potential clinical utility. This improvement suggests that combining genetic and lifestyle data may refine targeting for early intervention and resource allocation.

Expert Commentary

The findings align with growing evidence that polygenic risk contributes meaningfully to diabetes susceptibility across diverse ethnic backgrounds. From a clinical perspective, PRS may serve as an adjunct tool in risk stratification, especially in populations with distinct genetic architectures such as East Asians. However, the moderate effect size and overlap with lifestyle factors indicate PRS should complement, not replace, established risk assessments.

Limitations include the study’s restriction to Japanese cohorts, which may limit generalizability to other ethnicities. Furthermore, lifestyle data were self-reported, potentially introducing bias. Longitudinal studies are desirable to confirm causality and assess how integrating PRS influences clinical decision-making and patient outcomes.

Mechanistically, the multifactorial etiology of T2DM involves gene-environment interactions influencing insulin resistance and β-cell function. PRS capture cumulative genetic susceptibility to these pathophysiological processes. The observed lifestyle effects highlight the plasticity of disease risk, even when genetic susceptibility is elevated.

Conclusion

This study clearly demonstrates that polygenic risk scores are independently associated with type 2 diabetes risk in Japanese populations and enhance prediction beyond traditional clinical risk factors. Nevertheless, healthy lifestyle behaviors remain critically important in reducing diabetes risk, even among individuals with high genetic predisposition. These results advocate for integrating genetic data with lifestyle and clinical metrics to enable personalized risk assessment and targeted prevention interventions in type 2 diabetes.

Implications for Practice and Research

Incorporating PRS into routine diabetes risk screening may help identify high-risk individuals earlier, facilitating timely lifestyle counseling and potential pharmacologic prevention. Future research should explore how best to translate PRS information into actionable clinical strategies, evaluate cost-effectiveness, and examine patient acceptability. Multiethnic studies will also help confirm translatability across populations.

Funding and ClinicalTrials.gov

Funding details were not specified in the abstract. No clinical trial registration was mentioned.

References

Oshima M, Hara A, Toyama T, et al. Polygenic risk scores and lifestyle factors predicting new onset of type 2 diabetes in the Japanese general population. J Clin Endocrinol Metab. 2026 Sep 16;111(10):2890-2899. PMID: 41992540.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

HRS-7535: A Promising Oral GLP-1 Receptor Agonist for Type 2 Diabetes Uncontrolled by Metformin and SGLT2 InhibitorsThis Phase II trial demonstrates that HRS-7535, an oral small-molecule GLP-1 receptor agonist, significantly improves glycaemic control and is well-tolerated in type 2 diabetes patients inadequately controlled with metformin and SGLT2 inhibOct 19, 2026GLP-1 Receptor Agonists and Psychiatric Acute-Care Outcomes in Schizophrenia with Type 2 Diabetes: Insights from Real-World EHR DataThis review synthesizes evidence on GLP-1 receptor agonist initiation impacting psychiatric hospitalisation and emergency visits in adults with schizophrenia and type 2 diabetes, highlighting metabolic and psychiatric interplay and therapeuOct 19, 2026Survodutide Once Weekly in Adults with Obesity and Type 2 Diabetes: A Contemporary Review of Evidence and Clinical ImplicationsSurvodutide, a dual glucagon and GLP-1 receptor agonist, demonstrates significant weight loss and glycemic improvements in adults with obesity and type 2 diabetes, offering promise as a novel therapeutic agent with favorable efficacy and saOct 17, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Cardiology
Precision Medicine for Long QT Syndrome Type 2: Lumacaftor Corrects Trafficking Defects and Shortens QT Interval
General Surgery
Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Efficacy and Safety of the twiist Automated Insulin Delivery System in Insulin-Treated Type 2 Diabetes: A Comprehensive Review of the twiist-T2D Pivotal Trial and Related Evidence
The twiist AID system significantly improves glycemic control and patient satisfaction in insulin-treated type 2 diabetes over 13 weeks, demonstrating safety and effectiveness supported by complementary real-world and RCT data.
Oct 16, 2026
Retatrutide: A Breakthrough Triple Agonist for Obesity and Type 2 Diabetes ManagementRetatrutide, a triple agonist targeting GIP, GLP-1, and glucagon receptors, significantly reduces bodyweight and improves glycemic control in adults with obesity and type 2 diabetes, showing promising efficacy and a manageable safety profilOct 15, 2026
Quantifying the Surgeon’s Intuition: Visual Analog Scale as a Predictor of Postoperative OutcomesSurgeons’ preoperative subjective assessments quantified by visual analog scale significantly predict severe postoperative complications, enhancing traditional risk models for better perioperative prognosis.Oct 10, 2026